Table 1.
Groups | Family | Number of CNVloss | Number of CNVgain | Paternal Age | Maternal Age | F1’s Age | F1’s Sex |
---|---|---|---|---|---|---|---|
Control | CMA001-1F | 39 | 1 | 40 | 36 | 9 | Female |
CMA002-1F | 34 | 1 | 22 | 21 | 9 | Male | |
CMA003-1F | 20 | 1 | 26 | 26 | 25 | Female | |
CMA004-1F | 32 | 1 | 30 | 31 | 10 | Female | |
CMA005-1F | 29 | 2 | 42 | 31 | 5 | Female | |
CMA006-1F | 24 | 3 | 37 | 35 | 6 | Male | |
CMA007-1F | 27 | 3 | 47 | 36 | 9 | Male | |
F09-3F | 19 | 2 | 19 | 21 | 25 | Male | |
Total | — | 224 | 14 | — | — | — | — |
Case | F04-2F | 18 | 3 | 27a | 27 | 20 | Male |
F06-2F | 26 | 3 | 35a | 26 | 9 | Male | |
F07-1F | 26 | 5 | 54 | 24b | 19 | Male | |
F07-4F | 30 | 2 | 56 | 26b | 17 | Female | |
F08-2F | 13 | 5 | 18 | 20b | 8 | Male | |
F09-2F | 9 | 1 | 24c | 26c | 20 | Female | |
F10-2F | 16 | 1 | 21 | 24b | 2 | Female | |
F12-2F | 43 | 3 | 31 | 30b | 3 | Male | |
F15-2F | 26 | 0 | 18a | 27 | 16 | Male | |
F18-2F | 36 | 11 | 47a | 30 | 18 | Male | |
F21-2F | 18 | 2 | 38 | 27b | 20 | Female | |
F22-2F | 42 | 2 | 29 | 31b | 20 | Female | |
F22-3F | 45 | 2 | 32 | 34b | 17 | Female | |
F22-4F | 25 | 3 | 33 | 35b | 16 | Male | |
FAD-24F | 29 | 4 | 21a | 19 | 12 | Female | |
FAD-25F | 20 | 4 | 18a | 16 | 15 | Female | |
Total | — | 422 | 51 | — | — | — | — |
CNVloss: genomic losses; CNVgain: genomic gains. aExposed father; bexposed mother; and cboth parents exposed.